StemCells Begins Phase I/II Trial In Dry Age-Related Macular Degeneration

RELATED NEWS

StemCells Q4 Loss Narrows - Quick Facts

Trade STEM now with

6/21/2012 9:20 AM ET

StemCells, Inc. (STEM: Quote) on Thursday announced the initiation of a Phase I/II clinical trial of the company's proprietary HuCNS-SC product candidate (purified human neural stem cells) in dry age-related macular degeneration or AMD referred to as Geographic Atrophy.

Dry AMD is the most common form of macular degeneration. There are no approved treatments for the condition.

The trial is being conducted at the Retina Foundation of the Southwest's Anderson Vision Research Center in Dallas, Texas.

Click here to receive FREE breaking news email alerts for StemCells Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 107 Articles Next>>

Editors Pick

Stocks Climbing Well Off Lows After Early Sell-Off - U.S. Commentary

While stocks moved sharply lower at the start of trading on Thursday, selling pressure waned not long after the open. The markets have subsequently seen a notable recovery attempt, as some traders look to pick up stocks at reduced levels. The major averages have climbed well off their worst levels but are currently still posting modest losses.

U.S. New Home Sales Rise 2.3% In April, Coming In Well Above Estimates

In another upbeat sign for the U.S. housing market, the Commerce Department released a report on Thursday showing that new home sales came in well above economist estimates in the month of April. The report showed that new home sales climbed 2.3 percent to a seasonally adjusted annual rate of 454,000 in April from the revised March rate of 444,000.

Eurozone Consumer Confidence Improves For Sixth Month

Consumer sentiment in the euro area increased for the sixth consecutive month in May to its strongest level since the middle of last year, preliminary data from the European Commission showed Thursday. The DG ECFIN flash estimate of the consumer confidence indicator for Eurozone came in at -21.9,...